Biodistribution of N-alkyl and N-fluoroalkyl derivatives of spiroperidol; Radiopharmaceuticals for PET studies of dopamine receptors
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 13 (5) , 523-526
- https://doi.org/10.1016/0883-2897(86)90132-7
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Strategies for in vivo Measurement of Receptor Binding Using Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1986
- []-N-: The radioligand of choice for pett studies of the dopamine receptor in human brainLife Sciences, 1985
- Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidolThe International Journal of Applied Radiation and Isotopes, 1984
- A quantitative model for the in vivo assessment of drug binding sites with positron emission tomographyAnnals of Neurology, 1984
- Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: Potential agents for imaging the dopamine receptorLife Sciences, 1983
- Imaging Dopamine Receptors in the Human Brain by Positron TomographyScience, 1983
- Neuroleptic and dopamine receptors: Autoradiographic localization of [3H]spiperone in rat brainBrain Research, 1979
- Spiperone: A ligand of choice for neuroleptic receptorsBiochemical Pharmacology, 1978
- Dopamine receptor binding in vivo: The feasibility of autoradiographic studiesLife Sciences, 1978
- Specific in vivo binding of neuroleptic drugs in rat brainBiochemical Pharmacology, 1977